Startseite Medizin Replacement of breastfeeding with medical food for the treatment of galactosemia and phenylketonuria: maternal stress
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Replacement of breastfeeding with medical food for the treatment of galactosemia and phenylketonuria: maternal stress

  • Kleopatra Schulpis und Kostas Konstantinos Iakovou EMAIL logo
Veröffentlicht/Copyright: 7. Juni 2019

Abstract

Breastfeeding replacement is the only treatment for galactosemia (GAL) and phenylketonuria (PKU) during infancy. We aimed to evaluate the stress degree in mothers who were obliged to replace breastfeeding with special formulas as the only treatment for the diseased newborns. Thirty-two mothers with GAL newborns, 19 on breastfeeding only and 13 on breastfeeding plus formula, participated in this study. Additionally, 54 mothers with PKU infants, 32 offered breastfeeding only and 22 breastfeeding plus formula, participated in the study. Stress degree was evaluated in both groups: GAL and PKU. Mothers on breastfeeding only experienced the highest degree of stress than those who were on breastfeeding plus formula. After 1 month of psychological support, most mothers were ameliorated: mothers on breastfeeding only felt better as compared to those on breastfeeding plus formula. Conversely, in mothers on breastfeeding plus formulas, symptoms and signs of stress almost disappeared. In conclusion, GAL or PKU mothers with breastfeeding only experienced the highest degree of stress when asked for breastfeeding replacement. Psychological support made all the studied groups to feel better or free of symptoms and signs of stress.

  1. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  2. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  3. Research funding: None declared.

  4. Employment or leadership: None declared.

  5. Honorarium: None declared.

References

1. “Infant and young child feeding Fact sheet N°342”. WHO. February 2014. Archived from the original on 8 February 2015. Retrieved 8 February 2015.Suche in Google Scholar

2. Zetterstrom R. Breastfeeding and infant-mother interaction.Acta Paediatr 1999;88:1–6.10.1111/j.1651-2227.1999.tb01293.xSuche in Google Scholar

3. Fergusson DM, Woodward LJ. Breast feeding and later psychosocial adjustment. Paediatr Perinat Epidemiol 1999;13:144–57.10.1046/j.1365-3016.1999.00167.xSuche in Google Scholar

4. DeWitt SJ, Sparks JW, Swank PB, Smith K, Denson SE, et al. Physical growth of low birth weight infants in the first year of life: Impact of maternal behaviors. Early Hum Dev 1997;47:19–34.10.1016/S0378-3782(96)01757-4Suche in Google Scholar

5. Daws D. The perils of intimacy: closeness and distance in feeding and weaning. J Child Psychotherapy 1997;23:179–99.10.1080/00754179708254541Suche in Google Scholar

6. “Stress”. Mental Health America. 2013-11-18. Retrieved 2018-10-01.Suche in Google Scholar

7. World Health Organization. The role of WHO in public health. https://www.who.int/bulletin/volumes/89/9/11-086066/en/. Accessed: 19 April 2011.Suche in Google Scholar

8. Loukas YL, Soumelas GS, Dotsikas Y, Georgiou V, Molou E, et al. Expanded newborn screening in Greece: 30 months of experience. J Inherit Metab Dis 2010;33:341–8.10.1007/s10545-010-9181-8Suche in Google Scholar PubMed

9. Brumm VI, Bilder D, Waisbren SE. Psychiatric symptoms and disorders in phenylketonuria. Mol Genet Metab 2010;99:559–63.10.1016/j.ymgme.2009.10.182Suche in Google Scholar PubMed

10. Manta-Vogli P, Schulpis KH. Phenylketonuria dietary management and an emerging development. J Acad Nutr Diet 2017;17:2212–672.10.1016/j.jand.2017.05.020Suche in Google Scholar PubMed

11. Schulpis KH, Karakonstantakis T, Bartzeliotou A, Karikas GA, Papassotiriou I. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet. Clin Nutr 2004;23:401–7.10.1016/j.clnu.2003.09.006Suche in Google Scholar PubMed

12. Schulpis K, Thodi G, Iakovou K, Dotsikas Y, Molou E, et al. Mutational analysis on GALT gene in Greek patients with galactosemia: identification of two novel mutations and clinical evaluation. Scand J Clin Lab Invest 2017;77:423–7.10.1080/00365513.2017.1334262Suche in Google Scholar PubMed

13. Schoulpis K, Thodi G, Iakovou K, Dotsikas Y, Molou E, et al. Clinical evaluation and mutational analysis of GALK and GALE genes in patients with galactosemia in Greece: one novel mutation and two rare case. J Pediatr Endocrinol Metab 2017;30:775–9.10.1515/jpem-2017-0065Suche in Google Scholar PubMed

14. Schoulpis K, Thodi G, Iakovou K, Dotsikas Y, Molou E, et al. Rare cases of galactose metabolic disorders: identification of more than two mutations per patient. J Pediatr Endocrinol Metab 2017;30:1119–20.10.1515/jpem-2017-0263Suche in Google Scholar PubMed

15. Kramer MS, Aboud F, Mirinova E, Vanilovich I, Platt RW, et al. Breastfeeding and child cognitive development. Arch Gen Psychiatr 2008;65:578–84.10.1001/archpsyc.65.5.578Suche in Google Scholar PubMed

16. Der G, Batty GD, Deary IJ. Effect of breastfeeding on intelligence in children: prospective study, sibling pairs analysis, and meta-analysis. Br Med J 2006;333:945.10.1136/bmj.38978.699583.55Suche in Google Scholar PubMed PubMed Central

17. Huang J, Peters KE, Vaghn MG, Witko C. Breastfeeding and trajectories of children’s cognitive development. Dev Sci 2014;17:452–61.10.1111/desc.12136Suche in Google Scholar PubMed PubMed Central

18. Iakovou K, Kalogerakou M, Schulpis K. A patient with classical galactosemia is graduated with a university degree. J Pediatr Endocrinol Metab 2018;31:2018–294.10.1515/jpem-2018-0294Suche in Google Scholar PubMed

19. Iakovou K, Dotsikas Y, Loukas YL, Schulpis K. Classical galactosemia patients can achieve high IQ scores. J Pediatr Endocrinol Metab 2019;32:399–401.10.1515/jpem-2018-0515Suche in Google Scholar PubMed

20. Abou-Dakn M, Schafer-Graf U, Wockel A. Psychological stress and breast diseases during lactation. Breastfeeding Rev 2009;17:19–26.Suche in Google Scholar

21. Iakovou K, Madoglou A, Monopolis I, Schulpis K. The effect of PKU diet on the maternal quality of life and social discrimination in relation to their educational status and place of living. J Pediatr Endocrinol Metab 2019;32:281–285.10.1515/jpem-2018-0525Suche in Google Scholar PubMed

22. Iakovou K, Schulpis K. Web medical information produces anxiety to parents of a suspected for galactosemia infant. Rev Environ Health 2019. DOI: https://doi.org/10.1515/reveh-2018-0064.10.1515/reveh-2018-0064Suche in Google Scholar PubMed

23. Scrimshaw NS, Murray EB. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance. Am J Clin Nutr 1988;48:1142–59.10.1093/ajcn/48.4.1142Suche in Google Scholar PubMed

Received: 2019-03-02
Accepted: 2019-04-16
Published Online: 2019-06-07
Published in Print: 2019-07-26

©2019 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review
  3. Effect of safflower yellow on early type II diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials
  4. Original Articles
  5. Genomic study via chromosomal microarray analysis in a group of Romanian patients with obesity and developmental disability/intellectual disability
  6. Clinical and molecular characteristics and time of diagnosis of patients with classical galactosemia in an unscreened population in Turkey
  7. Assessment of retinal thickness as a marker of brain masculinization in children with congenital adrenal hyperplasia: a pilot study
  8. Auditory event-related potentials demonstrate early cognitive impairment in children with subclinical hypothyroidism
  9. Cardiovascular risk factors in children with type 1 diabetes mellitus
  10. The relationship between serum FGF-23 concentration and insulin resistance, prediabetes and dyslipidemia in obese children and adolescents
  11. The metabolic consequences of overweight in a cohort of children with type 1 diabetes
  12. The spectrum of pediatric adrenal insufficiency: insights from 34 years of experience
  13. Growth screening in children aged 3–5 years: a useful tool for public health programs in community pediatrics
  14. Selective receptor-mediated impairment of growth factor activity in neonatal- and X-linked adrenoleukodystrophy patients
  15. Determinants for low bone mineral density in pre-school children: a matched case-control study in Wuhan, China
  16. Genetic polymorphisms associated with obesity and non-alcoholic fatty liver disease in Asian Indian adolescents
  17. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes
  18. Severe, persistent neonatal hypoglycemia as a presenting feature in patients with congenital hypopituitarism: a review of our case series
  19. Case Reports
  20. Short stature in a boy with atypical progeria syndrome due to LMNA c.433G>A [p.(Glu145Lys)]: apparent growth hormone deficiency but poor response to growth hormone therapy
  21. A novel mutation leading to the lethal form of carnitine palmitoyltransferase type-2 deficiency
  22. Diagnosis of cyclic Cushing’s disease manifests as early morning hyperglycemia in a patient with previously well-controlled type 1 diabetes
  23. Short Communication
  24. Replacement of breastfeeding with medical food for the treatment of galactosemia and phenylketonuria: maternal stress
Heruntergeladen am 19.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2019-0109/pdf
Button zum nach oben scrollen